The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Gram-Negative Bacterial Infections

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Gram-Negative Bacterial Infections

 

High impact information on Gram-Negative Bacterial Infections

 

Chemical compound and disease context of Gram-Negative Bacterial Infections

 

Biological context of Gram-Negative Bacterial Infections

 

Anatomical context of Gram-Negative Bacterial Infections

 

Gene context of Gram-Negative Bacterial Infections

 

Analytical, diagnostic and therapeutic context of Gram-Negative Bacterial Infections

References

  1. Drosophila innate immunity: an evolutionary perspective. Hoffmann, J.A., Reichhart, J.M. Nat. Immunol. (2002) [Pubmed]
  2. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. Hoess, A., Watson, S., Siber, G.R., Liddington, R. EMBO J. (1993) [Pubmed]
  3. Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide. Japelj, B., Pristovsek, P., Majerle, A., Jerala, R. J. Biol. Chem. (2005) [Pubmed]
  4. In vivo RNA interference analysis reveals an unexpected role for GNBP1 in the defense against Gram-positive bacterial infection in Drosophila adults. Pili-Floury, S., Leulier, F., Takahashi, K., Saigo, K., Samain, E., Ueda, R., Lemaitre, B. J. Biol. Chem. (2004) [Pubmed]
  5. Dephosphorylation of endotoxin by alkaline phosphatase in vivo. Poelstra, K., Bakker, W.W., Klok, P.A., Kamps, J.A., Hardonk, M.J., Meijer, D.K. Am. J. Pathol. (1997) [Pubmed]
  6. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Lo, W.F., Woods, A.S., DeCloux, A., Cotter, R.J., Metcalf, E.S., Soloski, M.J. Nat. Med. (2000) [Pubmed]
  7. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Jack, R.S., Fan, X., Bernheiden, M., Rune, G., Ehlers, M., Weber, A., Kirsch, G., Mentel, R., Fürll, B., Freudenberg, M., Schmitz, G., Stelter, F., Schütt, C. Nature (1997) [Pubmed]
  8. Nitric oxide contributes to induction of innate immune responses to gram-negative bacteria in Drosophila. Foley, E., O'Farrell, P.H. Genes Dev. (2003) [Pubmed]
  9. Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria. Lu, M., Zhang, M., Takashima, A., Weiss, J., Apicella, M.A., Li, X.H., Yuan, D., Munford, R.S. Nat. Immunol. (2005) [Pubmed]
  10. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. Erridge, C., Stewart, J., Poxton, I.R. J. Exp. Med. (2003) [Pubmed]
  11. A nontoxic, idiotope vaccine against gram-negative bacterial infections. Su, S., Ward, M.M., Apicella, M.A., Ward, R.E. J. Immunol. (1992) [Pubmed]
  12. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. Golenbock, D.T., Hampton, R.Y., Qureshi, N., Takayama, K., Raetz, C.R. J. Biol. Chem. (1991) [Pubmed]
  13. Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A. Head, J.F., Mealy, T.R., McCormack, F.X., Seaton, B.A. J. Biol. Chem. (2003) [Pubmed]
  14. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections. LeFrock, J.L., Smith, B.R., Chandrasekar, P., Rolston, K.V., Molavi, A., Kannangara, W. Arch. Intern. Med. (1987) [Pubmed]
  15. Systemic infections treated with amdinocillin in combination with other beta-lactam antibiotics. King, J.W., Beam, T.R., Neu, H.C., Smith, L.G. Am. J. Med. (1983) [Pubmed]
  16. Requirement for STAT1 in LPS-induced gene expression in macrophages. Ohmori, Y., Hamilton, T.A. J. Leukoc. Biol. (2001) [Pubmed]
  17. In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters. Tomatsu, K., Masuyoshi, S., Hirano, M., Kawaguchi, H., Oki, T., Fung-Tomc, J., Desiderio, J.V., Kessler, R.E. Antimicrob. Agents Chemother. (1989) [Pubmed]
  18. Effect of a diazaborine derivative (Sa 84.474) on the virulence of Escherichia coli. Lam, C., Turnowsky, F., Högenauer, G., Schütze, E. J. Antimicrob. Chemother. (1987) [Pubmed]
  19. TNF-alpha and cyclooxygenase metabolites do not modulate C. albicans septic shock with disseminated candidiasis. Matuschak, G.M., Klein, C.A., Tredway, T.L., Schilly, D.R., Lechner, A.J. J. Appl. Physiol. (1993) [Pubmed]
  20. Murine beta-defensin-3 is an inducible peptide with limited tissue expression and broad-spectrum antimicrobial activity. Burd, R.S., Furrer, J.L., Sullivan, J., Smith, A.L. Shock (2002) [Pubmed]
  21. Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide. Hu, S.P., Harrison, C., Xu, K., Cornish, C.J., Geczy, C.L. Blood (1996) [Pubmed]
  22. Evaluation of aztreonam in experimental bacterial meningitis and cerebritis. Scheld, W.M., Brodeur, J.P., Gratz, J.C., Foresman, P., Rodeheaver, G. Antimicrob. Agents Chemother. (1983) [Pubmed]
  23. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. Malaviya, R., Abraham, S.N. J. Leukoc. Biol. (2000) [Pubmed]
  24. Vancomycin, trimethoprim-sulfamethoxazole, and rifampin. Lundstrom, T.S., Sobel, J.D. Infect. Dis. Clin. North Am. (1995) [Pubmed]
  25. Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells. Shuto, T., Kato, K., Mori, Y., Viriyakosol, S., Oba, M., Furuta, T., Okiyoneda, T., Arima, H., Suico, M.A., Kai, H. Biochem. Biophys. Res. Commun. (2005) [Pubmed]
  26. Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not. Sato, T., Miwa, T., Akatsu, H., Matsukawa, N., Obata, K., Okada, N., Campbell, W., Okada, H. J. Immunol. (2000) [Pubmed]
  27. Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model. Lettinga, K.D., Florquin, S., Speelman, P., van Ketel, R., van der Poll, T., Verbon, A. J. Infect. Dis. (2002) [Pubmed]
  28. Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Lehrnbecher, T., Bernig, T., Hanisch, M., Koehl, U., Behl, M., Reinhardt, D., Creutzig, U., Klingebiel, T., Chanock, S.J., Schwabe, D. Leukemia (2005) [Pubmed]
  29. The genes for the lipopolysaccharide binding protein (LBP) and the bactericidal permeability increasing protein (BPI) are encoded in the same region of human chromosome 20. Gray, P.W., Corcorran, A.E., Eddy, R.L., Byers, M.G., Shows, T.B. Genomics (1993) [Pubmed]
  30. Control of major histocompatibility complex class II expression on human monocytes by interleukin-4: regulatory effect of lipopolysaccharide. Hart, P.H., Bonder, C.S., Jones, C.A., Finlay-Jones, J.J. Immunology (1996) [Pubmed]
  31. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. Moore, R.D., Lietman, P.S., Smith, C.R. J. Infect. Dis. (1987) [Pubmed]
  32. Role of endogenous macrophage inflammatory protein-2 in regulating fever induced by bacterial endotoxin in normal and immunosuppressed rats. Miñano, F.J., Tavares, E., Maldonado, R. Clin. Exp. Pharmacol. Physiol. (2004) [Pubmed]
 
WikiGenes - Universities